In 2008, NCCN held its first program in Al Ain, UAE with more than 400 attendees. In 2009, with support in part from the Abu Dhabi Health Services Company (SEHA), NCCN will expand the program to a 3 day activity with anticipation of more than 750 participants. Regional panels in respective tumor types will convene prior to the Congress and bring with them proposed modifications to the NCCN Guidelines. These will be addressed during the breakout sessions. Participants will have developed the regional version at the end of the session. In addition, the collection of guidelines modifications will be published as a monograph in the JNCCN –The Journal of the National Comprehensive Cancer Network.
|
 
Program Agenda |
Untitled Document
| Thursday April 23, 2009 |
| 4:00-6:45 PM |
Welcome Reception |
| 7:00-9:00 PM |
Satellite Symposium sponsored by Novartis |
Friday April 24, 2009 |
| 8:00-8:30 AM |
Registration and Morning Coffee |
| 8:30-8:45 AM |
Welcome
Mohammad Jahanzeb, MD, Program Director
University of Tennessee Cancer Institute
Memphis, TN, USA
Jorgen Kristensen, MD, Program Co-Chair
Tawam Hospital
Al Ain, UAE
Al-Hareth Al- Khater, MD, Program Co-Chair
Al Amal Hospital
Doha, Qatar
Hamdy A. Azim, MD, MENA Steering Committee Chair
Cairo Oncology Center
Cairo, Egypt
|
| 8:50-9:05 AM |
Introduction and Overview of the NCCN
William T. McGivney, PhD
NCCN Chief Executive Officer |
| 9:10-9:20 AM |
The NCCN Guidelines Development Process
Joan S. McClure, MS
NCCN SVP, Clinical Information and Publications |
| 9:25-9:40 AM |
Regional Perspective on Prostate Cancer Management
Waleed Ahmed Hassen, MD
Tawam Hospital
Al Ain, UAE |
| 9:45-10:15 AM |
Break |
| 10:20-10:50 AM |
Overview of NCCN Prostate Cancer Guidelines
Sandy Srinivas, MD
Stanford Comprehensive Caner Center
Palo Alto, CA, USA |
| 10:55-11:10 AM |
Questions and Answers |
| 11:15-11:30 AM |
Regional Research Areas of Interest: Prostate Cancer
Panel Discussion |
| 11:35-11:55 AM |
Official Opening and Ribbon Cutting Ceremony |
| 12:00-2:30 PM |
Lunch |
| 2:35-2:50 PM |
Regional Perspective on Breast Cancer Management
Omalkhair Abdullah Abulkhair, MD
King Abdulaziz Medical City
Riyadh, Saudi Arabia |
| 2:55-3:25 PM |
Overview of NCCN Breast Cancer Guidelines
William J. Gradishar, MD
Robert H Lurie Comprehensive Cancer |
| 3:30-3:45 PM |
Questions and Answers |
| 3:45-4:15 PM |
Break |
| 4:20-4:35 PM |
Regional Research Areas of Interest: Breast Cancer
Panel Discussion |
| 4:35-6:35 PM |
Break-out Sessions for Prostate and Breast Cancers |
| 7:30-9:30 PM |
Satellite Symposium sponsored by Hoffmann-La Roche Ltd. |
Saturday April 25, 2009 |
| 8:00-8:20 AM |
Registration and Morning Coffee |
| 8:25-8:30 AM |
Welcome |
| 8:35-8:50 AM |
Regional Perspective on Non-Hodgkin's Lymphomas Management
Ali Bazarbachi, MD, PhD
American University of Beirut
Beirut, Lebanon |
| 8:55-9:25 AM |
Overview of NCCN Non-Hodgkin's Lymphoma Guidelines
Andrew D. Zelenetz, MD, PhD
Memorial Sloan-Kettering Cancer Center
New York, NY USA |
| 9:30-9:45 AM |
Questions and Answers |
| 9:50-10:05 AM |
Regional Research Areas of Interest Non-Hodgkin's Lymphomas
Panel Discussion |
| 10:10-10:40 AM |
Break |
| 10:45-11:00 AM |
Regional Perspective on Supportive Care Management
Vinod Raina, MD, FRCP
Institute Rotary Cancer Hospital
All India Institute of Medical Sciences
New Delhi, India |
| 11:05-11:35 AM |
NCCN Supportive Care Guidelines
David S. Ettinger, MD
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, MD, USA |
| 11:40-11:55 AM |
Questions and Answers |
| 12:00-12:15 PM |
Regional Research Areas of Interest: Supportive Care
Panel Discussion |
| 12:25-12:40 PM |
Regional Perspective on Lung Cancer Management
Abdul-Rahman Jazieh, MD, MPH
King Abdulaziz Medical City
Riyadh, Saudi Arabia |
| 12:45-1:15 PM |
Overview of NCCN Lung Cancer Guidelines
David S. Ettinger, MD
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, MD, USA
Mohammad Jahanzeb, MD, Program Director
University of Tennessee Cancer Institute
Memphis, TN, USA
|
| 1:20-1:35 PM |
Questions and Answers |
| 1:35-2:35 PM |
Lunch |
| 2:40-2:55 PM |
Regional Research Areas of Interest: Lung Cancer
Panel Discussion |
| 3:00-5:00 PM |
Breakout Sessions for Lung Cancer, NHL, Supportive Care |
| 5:00-7:00 PM |
Satellite Symposium sponsored by Bayer |
| 8:00-10:00 PM |
Gala Dinner |
Sunday April 26, 2009 |
| 8:00-8:30 AM |
Registration and Morning Coffee |
| 8:25-8:30 am |
Welcome |
| 8:30-8:45 AM |
Regional Perspective on Hepatobiliary Cancers Management
Muhammed Aasim Yusuf, MD
Shaukat Khanum Cancer Hospital
Lahore, Pakistan |
| 8:50-9:20 AM |
Overview of NCCN Hepatobiliary Guidelines
Al B. Benson, III, MD
Robert H. Lurie Cancer Center of Northwestern University
Chicago, IL, USA |
| 9:25-9:35 AM |
Questions and Answers |
| 9:40-9:55 AM |
Regional Research Areas of Interest: Hepatobiliary Cancers
Panel Discussion |
| 10:00-10:30 AM |
Break |
| 10:35-10:50 AM |
Regional Perspective on Colon Cancer Management
Fikri Icli, MD
Ankara University Medical School
Ankara, Turkey |
| 10:55-11:30 AM |
Overview of NCCN Colon Cancer Guidelines
Paul F. Engstrom, MD
Fox Chase Cancer Center
Philadelphia, PA, USA |
| 11:35-11:45 AM |
Questions and Answers |
| 11:50 AM-12:05 PM |
Regional Research Areas of Interest: Colon Cancer
Panel Discussion |
| 12:10-1:10 PM |
Lunch |
| 1:15-1:30 PM |
Closing Ceremony and Discussion on Continuation of NCCN MENA Guidelines Modification Project |
| 1:35-3:35 PM |
Break-out Session for Hepatobiliary and Colon Cancers |
|
|
|
|
Support |
This educational activity is supported by Novartis Oncology; Hoffmann-La Roche Ltd; GlaxoSmithKline; and Genomic Health Inc.
Additional congress supporters and exhibitors:
Astra Zeneca
Eli Lilly and Company
Janssen Cilag
LEO Pharma
Merck Serono
NeoBiocon
Pierre Fabre Oncology
sanofi aventis
Schering-Plough
|
The Armed Forces Officers Club
Abu Dhabi, UAE
www.afoc.mil.ae
The venue and conference hotel for the 2ndAnnual Middle East & North Africa (MENA) NCCN Clinical Practice Guidelines in Oncology™ Congress is the Armed Forces Officers Club in Abu Dhabi, UAE.
The Armed Forces Officers Club and Hotel is a brief 20 minute drive from the Abu Dhabi International Airport and is 1 hour and 10 minutes fromDubai International Airport. It is a five-star hotel with elegantly appointed accommodations including many suites. All rooms have brand new plasma televisions. The Hotel is complete with a fully-staffed business centre,Olympic-size swimming pool, and many other luxury amenities. It boasts eight restaurants serving a variety of international cuisine.The rates for the rooms at The Armed Forces Officers Club are as follows:
Single : $330 USD (1200 AED)
Double : $385 USD (1400 AED)
Executive Suite : $635 USD (2300 AED)
Executive Deluxe Suite : $720 (2600 AED)
Rates are subject to 10% Service Charge and 6% Tourism Fee. Breakfast is not included.
|
www.seha.ae
SEHA means health in Arabic. The Abu Dhabi Health Services Company – whose corporate identity is SEHA –is an independent, public joint stock company created to manage and develop the curative activities of the public hospitals and clinics of the Emirate of Abu Dhabi. SEHA is committed to providing quality, cost-effective healthcare on par with international standards measured through accessibility, affordability, choice and satisfaction.SEHA owns and operates 12 hospital facilities, 2,644 licensed beds, and more than 40 Ambulatory and Primary Healthcare Clinics. SEHA is one of the largest employers in the Middle East with more than 16,500 doctors, nurses,and other clinical staff and administration employed.
NCCN is grateful to SEHA for their generous financial support of this program.
|
www.nccn.org
The National Comprehensive Cancer Network (NCCN), a not-for-profit
alliance of 21 of the world’s leading cancer centers, is dedicated to
improving the quality and effectiveness of care provided to patients
with cancer. Through the leadership and expertise of
clinicalprofessionals at NCCN Member Institutions, NCCN develops
resources that present valuable information tothe numerous stakeholders
in the health care deliverysystem. As the arbiter of high-quality
cancer care, NCCN promotes the importance of continuous quality
improvement and recognizes the significance of creating clinical
practice guidelines appropriate for use by patients, clinicians, and
other health care decision-makers. The primary goal of all NCCN
initiatives is to improve the quality, effectiveness, and efficiency of
oncology practice so patients can live better lives.
|
|
